EurekaConnect Tackles the Inefficient Biomedical Product Pipeline

1 October, 2015

The Boston Business Journal reports on the important issue of bridging the gap between academia and biotechnology businesses in a two-part series on the EurekaConnect event held September 24th and 25th in Boston. Dr. Martha Farmer, CEO and President of NSIV, was a participant.

Read the first article here and the follow up story on day two here. The event focused on the big question of “How to make sure that the most promising such discoveries make it into the hands of a company with the knowledge and financing to oversee its development”.